Rafferty Asset Management, LLC Vir Biotechnology, Inc. Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

A detailed history of Rafferty Asset Management, LLC transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 173,852 shares of VIR stock, worth $1.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

173,852

Previous 145,847 19.2%

Holding current value

$1.3 Million

Previous $1.3 Million 0.31%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$7.26 - $10.7 $203,316 - $299,653	28,005 Added 19.2%	173,852 $1.3 Million
Q2 2024 Aug 13, 2024	SELL	$7.63 - $12.66 $2.24 Million - $3.72 Million	-293,476 Reduced 66.8%	145,847 $1.3 Million
Q1 2024 May 13, 2024	BUY	$8.6 - $11.9 $347,035 - $480,200	40,353 Added 10.11%	439,323 $4.45 Million
Q4 2023 Feb 13, 2024	SELL	$7.76 - $10.29 $980,452 - $1.3 Million	-126,347 Reduced 24.05%	398,970 $4.01 Million
Q3 2023 Nov 13, 2023	BUY	$9.14 - $24.62 $1.95 Million - $5.26 Million	213,477 Added 68.46%	525,317 $4.92 Million
Q2 2023 Aug 11, 2023	BUY	$23.2 - $27.29 $255,060 - $300,026	10,994 Added 3.65%	311,840 $7.65 Million
Q1 2023 May 11, 2023	SELL	$22.26 - $30.85 $168,753 - $233,873	-7,581 Reduced 2.46%	300,846 $7 Million
Q4 2022 Feb 13, 2023	SELL	$19.96 - $28.22 $22,954 - $32,453	-1,150 Reduced 0.37%	308,427 $7.81 Million
Q3 2022 Nov 14, 2022	BUY	$18.26 - $31.1 $2.64 Million - $4.49 Million	144,410 Added 87.43%	309,577 $5.97 Million
Q2 2022 Aug 12, 2022	SELL	$19.08 - $26.7 $1.52 Million - $2.13 Million	-79,670 Reduced 32.54%	165,167 $4.21 Million
Q1 2022 May 13, 2022	BUY	$21.19 - $40.01 $2.63 Million - $4.96 Million	123,896 Added 102.44%	244,837 $6.3 Million
Q4 2021 Feb 10, 2022	BUY	$30.97 - $54.03 $1.88 Million - $3.28 Million	60,674 Added 100.68%	120,941 $5.06 Million
Q3 2021 Nov 10, 2021	BUY	$34.9 - $54.54 $103,757 - $162,147	2,973 Added 5.19%	60,267 $2.62 Million
Q2 2021 Aug 10, 2021	SELL	$38.75 - $51.0 $5.85 Million - $7.7 Million	-150,966 Reduced 72.49%	57,294 $2.71 Million
Q1 2021 May 10, 2021	BUY	$26.34 - $83.07 $4.17 Million - $13.1 Million	158,277 Added 316.66%	208,260 $10.7 Million
Q4 2020 Feb 10, 2021	BUY	$25.51 - $43.38 $1.28 Million - $2.17 Million	49,983 New	49,983 $1.34 Million

Others Institutions Holding VIR

# of Institutions

218

Shares Held

87M

Call Options Held

127K

Put Options Held

1.19M

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $991M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Vir Biotechnology, Inc. Transaction History